Published in
Wiley Open Access, Cancer Medicine, 4(11), p. 1026-1036, 2022
DOI: 10.1002/cam4.4495
Links
Tools
A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations
Journal article published in 2022 by
Hong‐Shuai Li,
Jin‐Yao Zhang,
Xiang Yan,
Hai‐Yan Xu,
Xue‐Zhi Hao,
Pu‐Yuan Xing,
Yan Wang 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 